Serina Therapeutics Files 8-K: Officer/Director Changes & More
Ticker: SER · Form: 8-K · Filed: May 22, 2025 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, bylaws
TL;DR
Serina Therapeutics 8-K: Board shakeup, officer changes, and bylaws updated. Big governance news.
AI Summary
Serina Therapeutics, Inc. filed an 8-K on May 22, 2025, reporting on several key events. These include the departure of directors or certain officers, the election of directors, the appointment of certain officers, and updates to compensatory arrangements. The filing also covers amendments to articles of incorporation or bylaws, changes in fiscal year, and Regulation FD disclosures, along with financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate governance and operational updates for Serina Therapeutics, potentially impacting its strategic direction and investor relations.
Risk Assessment
Risk Level: medium — Changes in directors, officers, and bylaws can signal shifts in company strategy or internal dynamics, warranting closer investor scrutiny.
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 82-1436829 (ein) — IRS Employer Identification No.
- 601 Genome Way, Suite 2001 Huntsville, Alabama 35806 (address) — Principal Executive Offices
- AgeX Therapeutics, Inc. (company) — Former Company Name
- June 6, 2017 (date) — Date of Name Change
FAQ
Who specifically departed from Serina Therapeutics' board or officer positions?
The filing indicates the departure of directors or certain officers but does not name the individuals in this section of the provided text.
Were there any new directors or officers appointed?
Yes, the filing explicitly mentions the election of directors and the appointment of certain officers.
What specific amendments were made to the articles of incorporation or bylaws?
The filing notes amendments to articles of incorporation or bylaws, but the specific details of these amendments are not provided in this excerpt.
Does the filing include any updates on Serina Therapeutics' financial statements?
Yes, the filing indicates that financial statements and exhibits are included as part of the report.
What is the former name of Serina Therapeutics, Inc. and when did the name change occur?
The former name was AgeX Therapeutics, Inc., and the date of the name change was June 6, 2017.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Serina Therapeutics, Inc. (SER).